Abond CRO Hires Charley Bratton as Senior Vice President Corporate Marketing and Sales

Loading...
Loading...

Abond CRO Inc. announced today the hiring of Mr. Charley Bratton as Senior Vice President Corporate Marketing and Sales. This is a new position for the company and is a direct result of the growth and development the organization has experienced over the past few years.

According to Dr. Phil Doren, CEO, "Mr. Bratton will lead an array of activities contributing to the company's plans for accelerated growth and expansion of service offerings."

"Abond CRO is excited to have Charley join our company. He brings years of sales and marketing experience, industry-wide knowledge and an incredible amount of energy to this role. He is well-respected in the industry for providing client service excellence to meet drug and device development needs. Charley will add to the leadership team that we have in place to serve our pharmaceutical, biotech and medical device customers. His leadership experience and industry expertise in business development and marketing greatly enhances our organizational capability to provide excellent support in those areas to our customers," Doren added.

About Abond CRO Inc. (www.abondcro.com)

Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you'd expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...